pan style="color: #949494;">"</span>rIFN-g<span style="color: #949494;">"</span>  46/89 patients  </span></span>
<span><span class="co">#&gt; <span style="color: #BCBCBC;">4</span> qualifying patients <span style="color: #949494;">"</span>placebo<span style="color: #949494;">"</span> 36/74 patients  </span></span>
<span><span class="co">#&gt; <span style="color: #BCBCBC;">5</span> qualifying patients <span style="color: #949494;">"</span>rIFN-g<span style="color: #949494;">"</span>  38/74 patients  </span><